DURAMED COMPLETES ACQUISITION OF FEI WOMEN'S HEALTH AND PARAGARD IUD PRODUCT

Duramed Pharmaceuticals, Inc., a subsidiary of Barr Pharmaceuticals, Inc., today announced that it has completed the acquisition of FEI Women's Health, LLC. The closing of the transaction follows the termination of the Federal Trade Commission's review of the acquisition. FEI is the owner of ParaGard(R) T 380A (Intrauterine Copper Contraceptive) IUD, which is approved for continuous use for the prevention of pregnancy for up to 10 years. The definitive agreement under which Duramed would acquire FEI for $281.5 million was executed and announced on October 18, 2005.

Finanzen.net (http://finanzen.net/news/news_detail.asp?NewsNr=350135)